← Leaderboards
Jeffrey S Isenberg
University Of Pittsburgh At Pittsburgh
$2,984,184
Attributed
$3,966,987
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $965K · FY2008–16$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,966,987 · 4
By mechanism
R01$3,138,890 · 2
K22$597,659 · 1
R21$230,438 · 1
Top collaborators
- Patrick J Pagano5 shared
- Stephen F. Badylak1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Timothy R Billiar$30,423,539
- Charles Jeffery Woodbury$4,254,965
- Fadi G. Lakkis$19,632,585
- Stephen G. Weber$11,786,266
- J Peter Rubin$4,602,483
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayThrombospondin 1ReceptorBlood FlowCd47 GeneIn VivoNitric OxideBlood VesselsCellsVasodilationSmooth Muscle MyocytesBinding (Molecular Function)BaseSignal PathwaySignal TransductionKnockout MiceProteinsResistancePathogenesisPathway InteractionsReportingArteriesMyosin Light ChainsFunctional Disorder
Grant awards (13)
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular Dysfunction$500,500
R01 · FY2016 · HL
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular Dysfunction$379,225
R01 · FY2015 · HL
Augmentation of CD47 Signaling in Aging Exacerbates Cardiovascular Disease$115,500
R01 · FY2015 · HL
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular Dysfunction$376,993
R01 · FY2014 · HL
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth$357,541
R01 · FY2014 · HL · contact PI
Bioengineering Tracheas Through Targeting Activated CD47$230,438
R21 · FY2014 · EB · contact PI
TSP-1 and ROS: CD47 and SIRP-alpha as Mediators of Vascular Dysfunction$362,950
R01 · FY2013 · HL
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth$347,711
R01 · FY2013 · HL · contact PI
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth$319,577
R01 · FY2012 · HL · contact PI
TSP1-CD47 in Promotion of PAH-Associated Vasoconstriction and Vascular Overgrowth$378,893
R01 · FY2011 · HL · contact PI
Thrombospondin-1 Regulates Vascular Tone$214,853
K22 · FY2010 · CA · contact PI
Thrombospondin-1 Regulates Vascular Tone$229,743
K22 · FY2009 · CA · contact PI
Thrombospondin-1 Regulates Vascular Tone$153,063
K22 · FY2008 · CA · contact PI